Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly ...

Many people assume sleep apnea is stable, but the reality is very different, and some nights can be much worse than others, ...

People whose sleep apnea changes dramatically from night to night are 30% more likely to have a heart attack, stroke, or ...

Study finds people with severe sleep apnea face 71% higher risk of heart events, plus greater chances of obesity, diabetes, ...

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up ...

Variable aspects of obstructive sleep apnea were associated with an increased risk for major adverse cardio- and cerebrovascular events.

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep ...

Sleep apnea is a pretty common diagnosis among people of a certain age, and about half of those tested are diagnosed with some version of it. Most of us probably consider it a potential health risk ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...